MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery

Heart

Volumn 99, Issue 7, 2013, Pages 491-496

  Assenza, Gabriele Egidy ^a,b,c   Graham, Dionne A ^a   Landzberg, Michael J ^a,b   Valente, Anne Marie ^a,b   Singh, Michael N ^a,b   Bashir, Aamir ^a   Fernandes, Susan ^a   Mortele, Koenraad J ^d   Ukomadu, Chinweike ^b   Volpe, Massimo ^c,e   Wu, Fred ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d HARVARD MEDICAL SCHOOL   (United States)

^e IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

ADOLESCENT; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; FONTAN PROCEDURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE EXCLUDING INR SCORE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SUDDEN DEATH; SURVIVAL; UNITED STATES;

ADOLESCENT; ADULT; BILIRUBIN; BIOLOGICAL MARKERS; BOSTON; CHILD; CREATININE; DEATH, SUDDEN, CARDIAC; END STAGE LIVER DISEASE; FEMALE; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HEART FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HOSPITALS, PEDIATRIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875231837     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-303347     Document Type: Article

References (24)

1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971;26:240-8.
2. Khairy P, Poirier N, Mercier LA. Univentricular heart. Circulation 2007;115:800-12. (Pubitemid 46294747)
3. Gewillig M, Brown SC, Eyskens B, et al. The Fontan circulation: who controls cardiac output? Interact Cardiovasc Thorac Surg 2010;10:428-33.
4. Khairy P, Fernandes SM, Mayer JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008;117:85-92. (Pubitemid 350291185)
5. Dimopoulos K, Diller GP, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 2008;117:2320-8. (Pubitemid 351681557)
6. Camposilvan S, Milanesi O, Stellin G, et al. Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg 2008;86:177-82.
7. Kiesewetter CH, Sheron N, Vettukattill JJ, et al. Hepatic changes in the failing Fontan circulation. Heart 2007;93:579-84. (Pubitemid 46707109)
8. Matthews JC, Pagani FD, Haft JW, et al. Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation 2010;121:214-20.
9. Ailawadi G, Lapar DJ, Swenson BR, et al. Model for end-stage liver disease predicts mortality for tricuspid valve surgery. Ann Thorac Surg 2009;87:1460-7.
10. Cholongitas E, Marelli L, Shusang V, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006;12:1049-61. (Pubitemid 44063778)
11. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-71. (Pubitemid 30169932)
12. Heuman DM, Mihas AA, Habib A, et al. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl 2007;13:30-7. (Pubitemid 46099971)
13. Valente AM, Bhatt AB, Cook S, et al. AARCC (Alliance for Adult Research in Congenital Cardiology) Investigators. The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study. J Am Coll Cardiol 2010;56:144-50.
14. Giannico S, Hammad F, Amodeo A, et al. Clinical outcome of 193 extracardiac Fontan patients: the first 15 years. J Am Coll Cardiol 2006;47:2065-73.
15. d'Udekem Y, Iyengar AJ, Cochrane AD, et al. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 2007;116:I157-64. (Pubitemid 47480785)
16. Bock JS, Gottlieb SS. Cardiorenal syndrome: new perspectives. Circulation 2010;121:2592-600.
17. Tang WH, Mullens W. Cardiorenal syndrome in decompensated heart failure. Heart 2010;96:255-60.
18. Wu FM, Ukomadu C, Odze RD, et al. Liver disease in the patient with Fontan circulation. Congenit Heart Dis 2011;6:190-201.
19. Khambadkone S, Li J, de Leval MR, et al. Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation. Circulation 2003;107:3204-8. (Pubitemid 36793092)
20. Hager A, Fratz S, Hess J. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J 2009;30:507-8.
21. Reinhardt Z, Uzun O, Bhole V, et al. Sildenafil in the management of the failing Fontan circulation. Cardiol Young 2010;20:522-5.
22. Bernstein D, Naftel D, Chin C, et al. Pediatric Heart Transplant Study. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation 2006;114:273-80. (Pubitemid 44297093)
23. Jayakumar KA, Addonizio LJ, Kichuk-Chrisant MR, et al. Cardiac transplantation after the Fontan or Glenn procedure. J Am Coll Cardiol 2004;44:2065-72. (Pubitemid 39473293)
24. Lamour JM, Kanter KR, Naftel DC, et al. Cardiac Transplant Registry Database; Pediatric Heart Transplant Study. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol 2009;54:160-5.